AssureTrace Welcomes Graham Clark as New Business Director and Chief Revenue Officer

AssureTrace Appoints Graham Clark as Business Director and Chief Revenue Officer

AssureTrace, an Irish company innovating in the serialization management field for the pharmaceutical sector, has named Graham Clark as its new Business Director and Chief Revenue Officer. Clark, who has over 23 years of extensive international experience in serialization, also becomes a board member at AssureTrace. Previously a co-founder of TraceLink, he has been instrumental in shaping the landscape of regulations concerning drug traceability, including the EU's Falsified Medicines Directive (FMD) and the U.S. Drug Supply Chain Security Act (DSCSA).

As markets evolve, Clark addresses the pivotal challenge currently faced by pharmaceutical companies, which entails ensuring regulatory compliance consistently across various markets. He emphasizes that mere implementation of systems is no longer adequate; organizations must reliably maintain compliance day-to-day in diverse operational landscapes.

Clark elaborates, "Whether a company operates an advanced FMD system needing renewal or manages serialization across multiple markets, the challenge lies in keeping this specialized knowledge in-house. AssureTrace combines a structured operational model with established technology and managed service providers that pharma companies already know and trust. This synergy allows them to effectively manage regulatory obligations within routine operations."

The transition from on-premise solutions to managed services has been a significant paradigm shift in the industry, according to Clark. He notes, "The rationale for choosing managed services has evolved from mere cost-saving to leveraging specialized expertise, flexibility, and pace of response. When specialists handle routine tasks, introducing a new market or trading partner becomes a service modification rather than an internal project."

AssureTrace focuses on operational efficiency through a service-oriented model that integrates compliance processes, executed locally by qualified managed service providers, all adhering to a unified AssureTrace operational standard. This model leverages SoftGroup technology, which has replaced first-generation systems in 40 companies while clients retain regulatory oversight and responsibility.

Clark’s extensive experience and understanding of the serialization landscape within the pharma sector will be vital for expanding AssureTrace’s operations and partner network across Europe and North America. Venelin Dimitrov, co-founder and CEO of AssureTrace, states, "Graham’s insights will be instrumental as we build upon the established base of SoftGroup’s serialization technology, trusted by 167 pharma companies across 43 markets, achieving an impressive customer retention rate of 98%."

AssureTrace aims to enhance the ongoing operational compliance demands by implementing this service-oriented model, making strides in serialization solutions adaptable for the future of pharmaceuticals.

To learn more about AssureTrace and its innovative solutions, visit AssureTrace's website.